Health and Fitness Health and Fitness
Sat, May 8, 2010
[ 08:05 AM ] - Market Wire
Kindred Healthcare to Present at the Bank of America Merrill Lynch 2010 Health Care Conference
[ 07:00 AM ] - Market Wire
Teva Provides Update on Las Vegas Trial
[ 05:57 AM ] - Market Wire
ImmunoGen, Inc. Announces Webcast of Presentation .. k of America Merrill Lynch Health Care Conference
[ 05:57 AM ] - Market Wire
Kendall Law Group Investigates HealthTronics, Inc. Merger for Shareholders
[ 05:57 AM ] - Market Wire
Kendall Law Group Investigates SenoRx, Inc. Merger for Shareholders
[ 05:57 AM ] - Market Wire
PhotoMedex Announces Closing of Public Offering of Common Stock
Fri, May 7, 2010
[ 03:20 PM ] - Market Wire
Futuremed Announces Timing of Financial Results a .. l, and Information Relating to Unitholder Meeting
[ 05:30 AM ] - Market Wire
Presentation of Two Research Reports Involving Da .. t the 32nd Annual Meeting of the Society of Cardi
[ 05:00 AM ] - Market Wire
AVI BioPharma and Collaborators Publish Data From .. ating the Antimicrobial Efficacy of PMO Oligomers
[ 04:30 AM ] - Market Wire
Oncolytics Biotech(R) Inc. Announces Details of 2010 Annual Shareholder Meeting
[ 03:00 AM ] - Market Wire
Adeona Completes a $17.5 Million Corporate Partne .. velopment and Commercialization of Flupirtine for
[ 02:00 AM ] - Market Wire
MoneyTV; Pressure BioSciences, Inc.; Imaging3, In .. c.; Santa Fe Gold Corporation: MoneyTV with Donal
[ 01:24 AM ] - Market Wire
Baxter to Present at the Bank of America Merrill Lynch Health Care Conference
[ 01:01 AM ] - Market Wire
DUSA Pharmaceuticals Reports Notice of Allowance for Key PDT Device Patent
[ 01:00 AM ] - Market Wire
Premium Brands Holdings Corporation Announces 2010 First Quarter Results
Thu, May 6, 2010
[ 11:00 PM ] - Market Wire
CryptoLogic Announces Q1 2010 Results
[ 05:41 PM ] - Market Wire
AVANIR Pharmaceuticals Announces Pricing of Public Offering of Common Stock
[ 05:41 PM ] - Market Wire
BYDUREONa" FDA Review Timeline Set with PDUFA Action Date of October 22, 2010
[ 05:41 PM ] - Market Wire
Incyte Reports First Quarter 2010 Financial Results
[ 05:41 PM ] - Market Wire
ArQule Reports First Quarter 2010 Financial Results
[ 05:41 PM ] - Market Wire
Columbia Laboratories Reports First Quarter 2010 Financial Results
[ 05:41 PM ] - Market Wire
Exact Sciences Reports First-Quarter 2010 Financial Results
[ 05:41 PM ] - Market Wire
Ligand to Present at the MDB Capital Group Bright Lights Conference on May 11
[ 05:41 PM ] - Market Wire
Affymax® Reports First Quarter 2010 Financial Results
[ 05:41 PM ] - Market Wire
CytRx Reports 2010 First Quarter Financial Results
[ 05:41 PM ] - Market Wire
CPEX Pharmaceuticals Board of Directors Unanimous .. rs Reject Tender Offer Announced by Richard Rof©
[ 04:41 PM ] - Market Wire
Positron Showcased at NASDAQ Marketsite
[ 04:41 PM ] - Market Wire
Emergent BioSolutions Hosts Biopreparedness Forum for Members of the NATO Parliamentary Assembly
[ 04:41 PM ] - Market Wire
Odyssey HealthCare to Present at Bank of America Merrill Lynch Health Care Conference
[ 04:41 PM ] - Market Wire
Biogen Idec to Present at the Bank of America Merrill Lynch 2010 Healthcare Conference

Biogen Idec to Present at the Bank of America Merrill Lynch 2010 Healthcare Conference


Published on 2010-05-06 19:42:32 - Market Wire
  Print publication without navigation


CAMBRIDGE, Mass.--([ BUSINESS WIRE ])--Biogen Idec Inc. (NASDAQ: BIIB) announced today that its presentation at the Bank of America Merrill Lynch 2010 Healthcare Conference will be webcast live, via the internet, on Tuesday, May 11, 2010 at 4:20 p.m. EDT. To access the live webcast, please visit Biogen Ideca™s Investor Relations section (investor.biogenidec.com). An archived version of the webcast will be available for 14 days following the presentation.

About Biogen Idec

Biogen Idec creates new standards of care in therapeutic areas with high unmet medical needs. Biogen Idec is a global leader in the discovery, development, manufacturing, and commercialization of innovative therapies. Patients in more than 90 countries benefit from Biogen Idec's significant products that address diseases such as lymphoma, multiple sclerosis, and rheumatoid arthritis. For product labeling, press releases and additional information about the company, please visit [ www.biogenidec.com ].

Contributing Sources